ELEVATED ENVIRONMENTAL TEMPERATURES CAN INDUCE HYPERTHERMIA DURING D-FENFLURAMINE EXPOSURE AND ENHANCE 5-HYDROXYTRYPTAMINE (5-HT) DEPLETIONIN THE BRAIN

Citation
Cw. Stewart et al., ELEVATED ENVIRONMENTAL TEMPERATURES CAN INDUCE HYPERTHERMIA DURING D-FENFLURAMINE EXPOSURE AND ENHANCE 5-HYDROXYTRYPTAMINE (5-HT) DEPLETIONIN THE BRAIN, The Journal of pharmacology and experimental therapeutics, 283(3), 1997, pp. 1144-1150
Citations number
45
ISSN journal
00223565
Volume
283
Issue
3
Year of publication
1997
Pages
1144 - 1150
Database
ISI
SICI code
0022-3565(1997)283:3<1144:EETCIH>2.0.ZU;2-C
Abstract
d-Fenfluramine (d-Fen) has been demonstrated to alter body temperature (BT), decrease 5-hydroxytryptamine (5-HT) and decrease 5-HT plasma me mbrane transporters (PMT) in rats. Therefore, experiments were designe d to test whether a correlation existed between elevated BT and brain 5-HT depletions. It was hypothesized that d-Fen would induce hyperther mia if the environmental temperature was elevated. Experiments were co nducted to determine 1) the dose-response of d-Fen on BT in a 28 degre es C; environment, 2) the acute effect of d-Fen on long-term depletion of 5-HT and 5-HT PMT in a 4 degrees C, 22 degrees C or 28 degrees C e nvironment and 3) the effect of a 22 degrees C environment vs, a 28 de grees C environment on the plasma levels of d-Fen and d-norfenfluramin e, d-Fen produced a dose-dependent elevation of BT in the 28 degrees C environment, decreased BT in the 4 degrees C environment and had no e ffect on BT in the 22 degrees C environment. Exposure to d-Fen in the 4 degrees C or 22 degrees C environment reduced 5-HT and 5-HT PMT conc entrations compared with control. However, greater reductions of 5-HT and 5-HT PMT concentrations occurred in the 28 degrees C environment. Conversely, the plasma levels of d-Fen and d-norfenfluramine were not altered. Thus these experiments demonstrate that increased BT during d -Fen exposure occurs at elevated environmental temperatures without al tering the plasma concentrations of the drug and results in an enhance d long-term depletion of brain 5-HT and 5-HT PMT.